Beta Bionics, Inc. — Director's Dealing 2025

Dec 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-12-02

Reporting Person: Feider Stephen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-02	Common Stock	S	1427	$29.3359	Disposed	42614	Direct

Footnotes

F1: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.